Insider Transactions in Q1 2024 at Icu Medical Inc (ICUI)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 15
2024
|
Christian B. Voigtlander Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,780
-12.43%
|
$174,440
$98.08 P/Share
|
|
Mar 15
2024
|
Christian B. Voigtlander Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,247
+18.48%
|
-
|
|
Mar 15
2024
|
Ben Sousa Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
463
-12.24%
|
$45,374
$98.08 P/Share
|
|
Mar 15
2024
|
Ben Sousa Chief Information Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,299
+25.57%
|
-
|
|
Mar 15
2024
|
Daniel Woolson VP, GM-Infusion Capital |
SELL
Payment of exercise price or tax liability
|
Direct |
1,294
-7.66%
|
$126,812
$98.08 P/Share
|
|
Mar 15
2024
|
Daniel Woolson VP, GM-Infusion Capital |
BUY
Exercise of conversion of derivative security
|
Direct |
2,923
+14.74%
|
-
|
|
Mar 15
2024
|
Virginia Ruth Sanzone VP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
890
-11.99%
|
$87,220
$98.08 P/Share
|
|
Mar 15
2024
|
Virginia Ruth Sanzone VP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
1,624
+17.95%
|
-
|
|
Mar 15
2024
|
Brian Michael Bonnell Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,780
-6.66%
|
$174,440
$98.08 P/Share
|
|
Mar 15
2024
|
Brian Michael Bonnell Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,247
+10.83%
|
-
|
|
Mar 15
2024
|
Vivek Jain Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,671
-2.49%
|
$261,758
$98.08 P/Share
|
|
Mar 15
2024
|
Vivek Jain Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,871
+4.34%
|
-
|
|
Mar 15
2024
|
Daniel Woolson VP, GM-Infusion Capital |
SELL
Open market or private sale
|
Direct |
791
-5.36%
|
$77,518
$98.27 P/Share
|
|
Mar 14
2024
|
George A Lopez Director |
SELL
Open market or private sale
|
Indirect |
7,978
-0.9%
|
$805,778
$101.87 P/Share
|
|
Mar 12
2024
|
George A Lopez Director |
SELL
Open market or private sale
|
Direct |
1,522
-0.48%
|
$153,722
$101.51 P/Share
|
|
Mar 11
2024
|
George A Lopez Director |
SELL
Open market or private sale
|
Direct |
1,890
-0.59%
|
$196,560
$104.22 P/Share
|
|
Mar 08
2024
|
Daniel Woolson VP, GM-Infusion Capital |
SELL
Payment of exercise price or tax liability
|
Direct |
894
-5.71%
|
$92,976
$104.52 P/Share
|
|
Mar 08
2024
|
Daniel Woolson VP, GM-Infusion Capital |
BUY
Exercise of conversion of derivative security
|
Direct |
2,020
+11.42%
|
-
|
|
Mar 08
2024
|
Christian B. Voigtlander Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,210
-20.0%
|
$541,840
$104.52 P/Share
|
|
Mar 08
2024
|
Christian B. Voigtlander Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,499
+26.16%
|
-
|
|
Mar 08
2024
|
Ben Sousa Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
240
-8.81%
|
$24,960
$104.52 P/Share
|
|
Mar 08
2024
|
Ben Sousa Chief Information Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
674
+19.84%
|
-
|
|
Mar 08
2024
|
Vivek Jain Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,953
-2.83%
|
$619,112
$104.52 P/Share
|
|
Mar 08
2024
|
Vivek Jain Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,856
+4.84%
|
-
|
|
Mar 08
2024
|
Brian Michael Bonnell Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,210
-10.1%
|
$541,840
$104.52 P/Share
|
|
Mar 08
2024
|
Brian Michael Bonnell Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,499
+15.16%
|
-
|
|
Mar 08
2024
|
George A Lopez Director |
SELL
Open market or private sale
|
Direct |
15,372
-4.59%
|
$1,614,060
$105.94 P/Share
|
|
Mar 08
2024
|
Virginia Ruth Sanzone VP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,246
-17.69%
|
$129,584
$104.52 P/Share
|
|
Mar 08
2024
|
Virginia Ruth Sanzone VP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
2,273
+24.4%
|
-
|
|
Mar 08
2024
|
Virginia Ruth Sanzone VP, General Counsel |
SELL
Open market or private sale
|
Direct |
3,300
-40.89%
|
$343,200
$104.57 P/Share
|
|
Mar 07
2024
|
Daniel Woolson VP, GM-Infusion Capital |
SELL
Payment of exercise price or tax liability
|
Direct |
2,990
-9.87%
|
$313,950
$105.39 P/Share
|
|
Mar 07
2024
|
Daniel Woolson VP, GM-Infusion Capital |
BUY
Exercise of conversion of derivative security
|
Direct |
6,758
+17.25%
|
-
|
|
Mar 07
2024
|
Christian B. Voigtlander Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,234
-52.89%
|
$864,570
$105.39 P/Share
|
|
Mar 07
2024
|
Christian B. Voigtlander Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,017
+49.09%
|
-
|
|
Mar 07
2024
|
Ben Sousa Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,077
-29.87%
|
$113,085
$105.39 P/Share
|
|
Mar 07
2024
|
Ben Sousa Chief Information Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,003
+45.09%
|
-
|
|
Mar 07
2024
|
Vivek Jain Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
12,352
-5.87%
|
$1,296,960
$105.39 P/Share
|
|
Mar 07
2024
|
Vivek Jain Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
22,524
+9.29%
|
-
|
|
Mar 07
2024
|
Brian Michael Bonnell Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,234
-17.48%
|
$864,570
$105.39 P/Share
|
|
Mar 07
2024
|
Brian Michael Bonnell Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,017
+22.87%
|
-
|
|
Mar 07
2024
|
George A Lopez Director |
SELL
Open market or private sale
|
Direct |
18,954
-5.35%
|
$1,990,170
$105.77 P/Share
|
|
Mar 07
2024
|
Virginia Ruth Sanzone VP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
4,116
-20.31%
|
$432,180
$105.39 P/Share
|
|
Mar 07
2024
|
Virginia Ruth Sanzone VP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
7,509
+25.7%
|
-
|
|
Mar 04
2024
|
George A Lopez Director |
SELL
Open market or private sale
|
Direct |
7,051
-1.95%
|
$747,406
$106.79 P/Share
|
|
Mar 04
2024
|
Christian B. Voigtlander Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
13,603
-82.46%
|
$1,455,521
$107.56 P/Share
|
|
Feb 29
2024
|
Smiths Group International Holdings LTD |
SELL
Open market or private sale
|
Direct |
830,000
-33.2%
|
$87,980,000
$106.08 P/Share
|
|
Feb 29
2024
|
Smiths Group PLC |
SELL
Open market or private sale
|
Indirect |
830,000
-33.2%
|
$87,980,000
$106.08 P/Share
|
|
Feb 12
2024
|
Vivek Jain Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Indirect |
37,302
-29.6%
|
$3,879,408
$104.02 P/Share
|
|
Feb 12
2024
|
Vivek Jain Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
66,000
+34.38%
|
$3,828,000
$58.79 P/Share
|
|
Feb 12
2024
|
Vivek Jain Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
82,725
-48.65%
|
$8,603,400
$104.02 P/Share
|